These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 21453661

  • 1. End points for cisplatin ototoxicity.
    Qureshy K, Blakley B, Alsaleh S, Quddusi T, Berard S.
    J Otolaryngol Head Neck Surg; 2011 Feb; 40 Suppl 1():S45-8. PubMed ID: 21453661
    [Abstract] [Full Text] [Related]

  • 2. Effect of high-dose cisplatin on auditory brainstem responses and otoacoustic emissions in laboratory animals.
    Sockalingam R, Freeman S, Cherny TL, Sohmer H.
    Am J Otol; 2000 Jul; 21(4):521-7. PubMed ID: 10912698
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Recovery of hearing following cisplatin ototoxicity in the guinea pig.
    O'Leary SJ, Klis SF.
    Anticancer Res; 2002 Jul; 22(3):1525-8. PubMed ID: 12168832
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Detection of late ototoxic side effect of cisplatin by distortion otoacoustic emission (DPOAE)].
    Biró K, Noszek L, Prekopp P, Nagyiványi K, Géczi L, Gaudi I, Bodrogi I.
    Magy Onkol; 2006 Jul; 50(4):329-35. PubMed ID: 17216007
    [Abstract] [Full Text] [Related]

  • 8. Intratympanic dexamethasone to prevent cisplatin ototoxicity: a guinea pig model.
    Murphy D, Daniel SJ.
    Otolaryngol Head Neck Surg; 2011 Sep; 145(3):452-7. PubMed ID: 21521888
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A clinically derived guinea pig dosing model of cisplatin ototoxicity.
    Stanford JK, Bosworth NA, Morgan DS, Chen T, Spankovich C.
    Hear Res; 2021 May; 404():108202. PubMed ID: 33621791
    [Abstract] [Full Text] [Related]

  • 12. Protective role of resveratrol against cisplatin induced ototoxicity in guinea pigs.
    Yumusakhuylu AC, Yazici M, Sari M, Binnetoglu A, Kosemihal E, Akdas F, Sirvanci S, Yuksel M, Uneri C, Tutkun A.
    Int J Pediatr Otorhinolaryngol; 2012 Mar; 76(3):404-8. PubMed ID: 22261612
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Ototoxicity, nephrotoxicity and pharmacokinetics of cisplatin and its monohydrated complex in the guinea pig.
    Ekborn A, Lindberg A, Laurell G, Wallin I, Eksborg S, Ehrsson H.
    Cancer Chemother Pharmacol; 2003 Jan; 51(1):36-42. PubMed ID: 12497204
    [Abstract] [Full Text] [Related]

  • 16. Characteristics and risk factors of cisplatin-induced ototoxicity in testicular cancer patients detected by distortion product otoacoustic emission.
    Biro K, Noszek L, Prekopp P, Nagyiványi K, Géczi L, Gaudi I, Bodrogi I.
    Oncology; 2006 Jan; 70(3):177-84. PubMed ID: 16757924
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Electrophysiological evaluation of the hearing function following cisplatin administration].
    Bogomol'skiĭ MR, D'iakonova IN, Rakhmanova IV, Sapozhnikov IaM, Stakhovskaia OR, Tikhomirov AM.
    Vestn Otorinolaringol; 2010 Jan; (3):24-6. PubMed ID: 20559247
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.